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Axon growth requires the coordinated regulation of gene expression in the neuronal soma,
local protein translation in the axon, anterograde transport of synthesized raw materials
along the axon, and assembly of cytoskeleton and membranes in the nerve growth cone.
Glycogen synthase kinase 3 (GSK3) signaling has recently been shown to play key roles
in the regulation of axonal transport and cytoskeletal assembly during axon growth. GSK3
signaling is also known to regulate gene expression via controlling the functions of many
transcription factors, suggesting that GSK3 may be an important regulator of gene tran-
scription supporting axon growth. We review signaling pathways that control local axon
assembly at the growth cone and gene expression in the soma during developmental or
regenerative axon growth and discuss the potential involvement of GSK3 signaling in these
processes, with a particular focus on how GSK3 signaling modulates the function of axon
growth-associated transcription factors.
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INTRODUCTION
During development of the nervous system, an important step in
forming the neural circuitry is directed axon extension from post-
mitotic neurons to reach their synaptic targets. To induce axon
extension, the cellularmachinery at the nerve growth cone controls
the assembly of cytoskeletal proteins and membrane components
into new axons. For sustained axon growth over long distance,
gene expression at the neuronal soma is also required to provide
signaling molecules that control the intrinsic axon growth ability
and raw materials that support axon assembly (Zhou and Snider,
2006). Active axon extension is also important in adult animals
after nerve injuries, when axotomized axons need to regenerate
back to their original synaptic targets for functional recovery. It is
well-known that neurons in the mature mammalian central ner-
vous system (CNS) do not regenerate their axons after the injury,
largely because of their reduced intrinsic axon growth ability and
the hostile environment that blocks local axon assembly at the
growth cone (Yiu andHe, 2006; Liu et al., 2011). Therefore, under-
standing the two fundamental aspects of axon growth, i.e., local
axon assembly at the growth cone and gene expression in the soma,
is very important in the study of how axon growth is regulated in
development and why axons in the mature CNS fail to regenerate
after injuries.
During the past decades, extensive studies have shown how
extracellular factors (neurotrophic or guidance), through their
receptors and downstream signaling mediators, control axon
assembly or pathﬁnding locally at the growth cone (Lowery and
Van Vactor, 2009). In contrast, we know relatively less about the
signaling events occurring at the neuronal soma that controls gene
expression during axon growth. For instance, little is known about
the transcription factors and the targeted genes they control that
speciﬁcally regulate axon growth downstream of neurotrophic
factors.We know even less about howaxon growth-associated gene
expression at the soma is coordinated with local axon assembly at
the growth cone. In this review, we summarize signaling pathways
that regulate local axon assembly or gene expression during axon
growth and discuss the potential role of glycogen synthase kinase
3 (GSK3) signaling in these two processes, with a particular focus
on regulation of gene expression.
MODEL SYSTEMS FOR STUDYING AXON GROWTH
To study axon growth during development,many types of primary
cultured neurons have been used, such as sensory and sympathetic
neurons in the peripheral nervous system (PNS), as well as reti-
nal ganglion cells (RGCs), cortical neurons, hippocampal neurons,
and cerebellar granule cells in the CNS. In vitro, these embryonic
neurons can be cultured easily, and they extend axons in response
to deﬁned neurotrophic factors. In vivo, genetic deletion of neu-
rotrophic factors or their receptors has been used to study the
regulation of axon growth during development (Patel et al., 2000,
2003; Kuruvilla et al., 2004).
For studying axon growth in adult neurons, the models are
limited to a few PNS neuronal types that can regenerate after
injuries. Among them,dorsal root ganglion (DRG) neurons regen-
erate robustly after peripheral nerve injuries. Each DRG neuron
possesses one axon stemming from the cell body that branches
into two axons: a peripheral descending axon branch innervating
peripheral targets and an ascending central branch that projects
into the dorsal column of the spinal cord. The peripheral branches
of the DRG neurons regenerate readily after peripheral nerve
injury, and therefore a crush model of this nerve is widely to
study the mechanisms that regulate axon regeneration in vivo.
In contrast, the central branches of DRG neurons do not regen-
erate after the spinal cord injury. However, if peripheral axotomy
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occurs before the dorsal column injury (a process called condi-
tioning lesion), the central branches can grow beyond the injury
site in the spinal cord (Neumann and Woolf, 1999). Importantly,
the central axons of DRG neurons share the same hostile CNS
environment with descending corticospinal axons in the spinal
cord, making the study relevant for CNS axon regeneration. As a
result, injury of the DRG central axons in the spinal cord is a well-
accepted model for investigating approaches that promote axon
regeneration. After a conditioning lesion, dissociated adult DRG
neurons can extend long axons in culture, which is increasingly
used as an in vitro model system for studying regenerative axon
growth (Zhou et al., 2006).
SIGNALING PATHWAYS MEDIATING DEVELOPMENTAL AND
REGENERATIVE AXON GROWTH: COORDINATION BETWEEN
GENE EXPRESSION AND LOCAL AXON ASSEMBLY
EXTRACELLULAR FACTORS SUPPORTING AXON GROWTH DURING
DEVELOPMENT
Axon extension does not occur autonomously from the newly
differentiated neurons, and extracellular signals are absolutely
necessary to induce and support long distance axon growth (Gold-
berg et al., 2002; Goldberg, 2003). These extracellular factors
induce axon growth by activating gene expression in the soma
and local axon assembly at the growth cone. Among all the char-
acterized neurotrophic factors, the most extensively studied are
growth factors, especially the neurotrophin family proteins, such
as the nerve growth factor (NGF), neurotrophin-3 (NT3), and
brain-derived neurotrophic factor (BDNF). In cultured sympa-
thetic ganglion neurons or DRG neurons, NGF and NT3 induce
robust axon growth by activation of their corresponding recep-
tors, TrkA and TrkC, respectively (Lentz et al., 1999; Markus et al.,
2002). However, in vivo study of developing DRG neurons lacking
TrkA has shown that NGF signaling is required only for termi-
nal axon arborization, not for initial axon extension (Patel et al.,
2000). Similar results were also reported in developing trigemi-
nal ganglion neurons and sympathetic neurons (O’Connor and
Tessier-Lavigne, 1999; Kuruvilla et al., 2004). To date, the identi-
ties of neurotrophic factors that mediate initial axon growth from
these PNS neurons in vivo remain unknown. BDNF is able to
induce axon growth of hippocampal neurons via its receptor TrkB
in vitro (Labelle and Leclerc, 2000; Cheng et al., 2011). However,
whether it regulates axon growth of these CNS neurons in vivo is
not clear. Insulin-like growth factor 1 (IGF-1) has been shown to
control axon growth of corticospinal motor neurons both in vitro
and in vivo (Ozdinler and Macklis, 2006).
By using a compartmentalized culture system (i.e., the Camp-
enot chamber) that can separate neuronal soma from their axons,
studies of sympathetic neurons have revealed that application of
NGF only at the soma compartment is not sufﬁcient to promote
axon growth into the axonal compartment, indicating that local
NGF signaling at the growth cone is required for inducing axon
growth (Campenot, 1977, 1982a,b). In addition, gene transcrip-
tion, which occurs in the neuronal soma, is necessary to support
sustained axon growth (Bodmer et al., 2011). Together, these stud-
ies have established that activation of neurotrophic signaling both
in the neuronal soma and locally at the growth cone is necessary
for efﬁcient axon extension.
INTRACELLULAR SIGNALING REGULATING AXON GROWTH DURING
DEVELOPMENT
Both the Trk receptors and the IGF-1 receptor belong to the family
of receptor tyrosine kinases (RTKs), which transduce their sig-
nals through twomajor downstreammediators,MAPK and PI3K.
A compartmentalized culture study has shown that both MAPK
and PI3K are required locally at the growth cone to regulate axon
assembly (Atwal et al., 2000). PI3K pathway is well recognized as
a major regulator of local axon assembly. In support, PI3K activ-
ity is necessary for the local application of NGF-induced axonal
branching or axon pathﬁnding (Gallo and Letourneau, 1998;Ming
et al., 1999). PI3K controls local axon assembly largely through its
ability to regulate the neuronal cytoskeleton. For instance, PI3K
acts upstream of the small GTPases Rac and Cdc42, both of which
are key regulators of actin ﬁlaments (Cantley, 2002). In line with
its role in the regulation of actin dynamics, activated PI3K is
localized at the leading edge of the growth cone, where actin poly-
merization occurs (Zhou et al., 2004). Moreover, PI3K can also
regulate microtubule dynamics in the growth cone via GSK3 and
its downstream microtubule-binding proteins (Zhou et al., 2004).
How MAPK pathway regulates local axon assembly at the growth
cone is less clear because a direct link between the MAPK path-
way and the growth cone cytoskeleton is still lacking. However,
MAPK pathway has been shown to control local protein synthe-
sis in axons in response to guidance cues (Campbell and Holt,
2003), which may indirectly contribute to regulation of local axon
assembly. At the neuronal soma,MAPK signaling has been shown
to control neurotrophin-induced axon growth by regulation of
gene expression via the transcription factor cyclic AMP response
element-binding protein (CREB; Lonze et al., 2002), and/or the
serum response factor (SRF;Wickramasinghe et al., 2008). In con-
trast, there is no evidence that PI3K regulates gene transcription
during neurotrophin-induced axon growth. Taken together, the
evidence to date suggests that in neurotrophin-induced develop-
mental axon growth MAPK and PI3K share a division of labor
with MAPK mainly controlling gene expression in the soma and
PI3K mainly controlling local axon assembly at the growth cone.
INTRACELLULAR SIGNALING REGULATING AXON REGENERATION
In contrast to axon growth during embryonic development, only
limited neuronal types in the mammalian PNS can regenerate
after injuries. As a result, very little is known about the sig-
naling pathways that control naturally occurring axon regener-
ation. An attractive hypothesis is that mature neurons may con-
trol axon regeneration by recapitulating signaling pathways that
control developmental axon growth. Indeed, many axon growth-
associated proteins are re-expressed in adult neurons to support
axon regeneration after the injury (i.e., GAP43). However, the
environment in which axon growth occurs in development is
drastically different from that during axon regeneration. In addi-
tion, the regenerating axons need to travel much longer distances
than developing axons because of their larger body size. These
differences suggest that regenerating neurons may use distinct sig-
naling pathways to control axon growth. In support, two studies
have compared axon growth from the same DRG neurons dur-
ing development and regeneration (Liu and Snider, 2001; Zhou
et al., 2006). They showed that in adult DRG neurons neither
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MAPK nor PI3K pathway was necessary for conditioning lesion-
induced local axon assembly, which is in strong contrast to that
of neurotrophin-induced developmental axon assembly. Instead,
both in vitro and in vivo studies (Werner et al., 2000; Zhou et al.,
2006) have suggested that the integrin pathway play an impor-
tant role in mediating PNS axon regeneration by controlling local
axon assembly. Moreover, the transcription factor c-Jun has been
shown to speciﬁcally regulate axon growth during regeneration
but not development (Raivich et al., 2004; Saijilafu et al., 2011).
Together, these studies indicate that mature neurons use differ-
ent signaling pathways to control gene expression and local axon
assembly during axon regeneration, although these pathways may
control developmental and regenerative axon growth via simi-
lar axon growth-associated proteins (i.e., GAP43 and cytoskeletal
proteins).
Comparing to developmental axon growth, we know much
less about pathways that speciﬁcally regulate axon regeneration.
In a mouse genetic study (Eickholt et al., 2007), in which the
catalytic subunit of PI3K p110δ was mutated to an inactivated
form, axon regeneration of adult DRG neurons was signiﬁcantly
reduced. Because PI3K is not required for local axon assembly
of regenerating adult DRG neurons (Liu and Snider, 2001; Zhou
et al., 2006), this result suggests that PI3K signaling is speciﬁ-
cally involved in regulation of gene expression in the neuronal
soma during axon regeneration. Indeed, in the p110δ mutant
mice the peripheral nerve axotomy-induced up-regulation of the
regeneration-associated gene (RAG) SPRR1A was substantially
reduced compared with wild-type mice. Additional studies, in
which PI3K activity is speciﬁcally manipulated in the neuronal
soma or axons, are needed to test this hypothesis.
EXTRACELLULAR FACTORS PROMOTING AXON REGENERATION
Several recent studies have shown that after optical nerve
injury, astrocyte-derived ciliary neurotrophic factor (CNTF) or
macrophage-derived oncomodulin can promote RGNaxon regen-
eration (Yin et al., 2006, 2009; Muller et al., 2007; Leibinger et al.,
2009). CNTF promotes axon regeneration via the JAK–STAT sig-
naling pathway (Muller et al., 2007), which is negatively regulated
by the suppressor of cytokine signaling 3 (SOCS3; Smith et al.,
2009). Pharmacological inhibition of JAK2 has been shown to
block regenerative axon growth of adult DRG neurons induced by
conditioning lesion (Liu and Snider, 2001). Because such in vitro
axon regeneration is transcription independent (Zhou et al., 2006),
this result suggests that JAK2plays a local role in regulation of axon
assembly at the growth cone. Moreover, genetic deletion of STAT3
in DRG neurons impairs peripheral axon regeneration (Qiu et al.,
2005). Conversely, overexpression of STAT3 promotes the regen-
eration of DRG central axons in the spinal cord (Bareyre et al.,
2011). These studies indicate that the JAK–STAT pathway controls
axon regeneration by coordinating gene expression (via STAT3)
and local axon assembly (via JAK2).
GSK3 SIGNALING IN AXON GROWTH AND REGENERATION
Glycogen synthase kinase 3 is a unique kinase because it is usu-
ally activated in resting cells, which acts to suppress cell signal-
ing. In response to extracellular stimuli, it is inactivated to allow
propagation of the signal transduction cascades (Hur and Zhou,
2010). PI3K is one of the important upstream regulators of GSK3.
Activation of the PI3K pathway is believed to inactivate GSK3
by phosphorylating its amino-terminal serine residue (Ser21 in
GSK3α and Ser9 in GSK3β) via Akt. However, when such serine
residue is replacedwith alanine, the resultedmutantmice (GSK3α-
Ser21Ala/GSK3β-Ser9Ala double knockinmice) develop normally
without obvious phenotype in the nervous system (McManus
et al., 2005), suggesting that GSK3 inactivation downstream of
PI3K might be mediated by alternative pathways. The canonical
Wnt pathway is another important regulator of GSK3 activity. In
the absence of the Wnt ligand, GSK3 forms a protein complex
with Axin, β-catenin, and adenomatous polyposis coli (APC). As
a result, GSK3 phosphorylates β-catenin, leading to its degrada-
tion through the ubiquitin-mediated proteasome (UPS) pathway.
Upon activation of the Wnt signaling, GSK3 is dissociated from
the β-catenin complex and inactivated, resulting in β-catenin sta-
bilization and the subsequent gene expression. How theWnt path-
way inactivates GSK3 is not fully understood, but it may involve
being recruited to the Wnt co-receptor low-density-lipoprotein
receptor-related protein 5/6 (LRP 5/6) on the membrane (Piao
et al., 2008; Wu et al., 2009) or being sequestered from the cytosol
into multivesicular bodies (Taelman et al., 2010).
An important step in axon extension is the continuous addi-
tion microtubules at the nerve growth cone. Such process is
tightly controlled by a battery of cytoskeletal proteins, such as
the collapsin response mediator protein 2 (CRMP2), the classic
microtubule-associated proteins (MAP1b and Tau), the micro-
tubule plus end-tracking protein (+TIPs, APC, and CLASP),
the microtubule-severing proteins (katanin and spastin), the
microtubule-depolymerizing factors (MCAK/KIF2c and stath-
min), the microtubule-based motor proteins (kinesin-5 and
dynein), and the actin-based motor protein (non-muscle myosin
II). These cytoskeletal proteins coordinate microtubule assembly
at the growth cone to support axon extension (Kim et al., 2011).
Surprisingly, many of these proteins, including CRMP2, APC,
CLASP,MAP1b, Tau, stathmin, and myosin II, are validated GSK3
substrates (Hanger et al., 1992; Rubinfeld et al., 1996; Moreno and
Avila, 1998; Cole et al., 2004; Trivedi et al., 2005; Kim et al., 2009;
Kumar et al., 2009), whereas others, including katinin and KIF2c
(Taelman et al., 2010), contain conserved GSK3 sites. Thus, GSK3
is emerging as a major regulatory molecule in the growth cone
for controlling local axon assembly (Zhou et al., 2004; Zhou and
Snider, 2005; Hur and Zhou, 2010; Hur et al., 2011).
There is increasing evidence that GSK3 is also an important
regulator of gene expression. For instance, in a recent study, GSK3
in quiescent non-neuronal cells was directly inhibited with phar-
macological inhibitors, showing that GSK3 inactivation alone is
sufﬁcient to induce gene expression in the absence of growth factor
stimulation (Tullai et al., 2011). Additional analysis showed that
these GSK3 inhibition-induced genes were regulated by a tran-
scriptional network downstream of three families of transcription
factors: CREB, NFκB, and AP-1. Similarly, in rat cortical neurons,
knocking down GSK3α or GSK3β activates CREB, NFκB, and AP-
1, along with other transcription factors such as TCF4, GRE, and
Smad3/4 (Liang and Chuang, 2006). These studies provide clear
evidence that GSK3 signaling can orchestrate multiple transcrip-
tion factors to control a speciﬁc pattern of gene expression. Todate,
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there is no direct evidence that GSK3-mediated gene expression is
involved in regulation of axon growth. One study has shown that
Wnt3a can induce axon growth from embryonic DRG neurons via
its receptor Ryk independent of the neurotrophin signaling (Lu
et al., 2004). Through the same Ryk receptor,Wnt3a also activates
the transcription factor TCF4, which is regulated by the GSK3-
β-catenin pathway. This result suggests that GSK3-mediated gene
transcription via β-catenin-TCF4 may underlie Wnt3a-induced
axon growth, although it was not tested in that study. Moreover,
because Ryk receptor is also localized in the growth cone (Lu
et al., 2004),Wnt3a may also control local axon assembly through
the GSK3 pathway. Thus, GSK3 may function to coordinate gene
expression in the soma and axon assembly at the growth cone
during Wnt3a-induced axon growth. Inhibition of GSK3 with
multiple pharmacological inhibitors, lithium and SB415286, has
been shown to promote both axon sprouting and regeneration of
corticospinal neurons across the lesion site (Dill et al., 2008). In
that study, the promoting effect was attributedmainly to the effect
of GSK3 inhibition on overcomingCNS inhibitors. However,mul-
tiple studies have indicated that overcoming CNS inhibitors alone
is not sufﬁcient to promote corticospinal axon regeneration and
that enhanced intrinsic axon growth ability is required (Liu et al.,
2011). Therefore, it is suggested thatGSK3 inhibition promotes the
intrinsic axon regeneration ability of adult corticospinal neurons,
presumably via regulation of gene expression.
In summary, GSK3 signaling can regulate local axon assem-
bly through cytoskeletal proteins and gene expression through
transcription factors. Because GSK3 inhibitor lithium has been
used clinically for decades and more speciﬁc inhibitors are being
actively developed for treating psychological disorders, inhibition
of GSK3 will be an attractive new approach for promoting axon
regeneration after CNS injuries.
POTENTIAL ROLE OF GSK3 SIGNALING IN REGULATION OF
AXON GROWTH-ASSOCIATED TRANSCRIPTION FACTORS
DURING DEVELOPMENT AND REGENERATION
To date, many transcription factors have been identiﬁed for regu-
lating axon growth during development or regeneration, includ-
ing CREB, nuclear factor of activated T-cells (NFATc), protein
53 (p53), nuclear factor κB (NFκB), c-Jun, Smads, SnoN, E47,
inhibitor of DNA-binding 2 (Id2), activating transcription fac-
tor 3 (ATF3), signal transducer and activator of transcription
3 (STAT3), SRF, Sox11, and Kruppel-like factors (KLFs). Many
of these proteins are well-established GSK3 substrates, includ-
ing CREB, NFATc, p53, NFκB, c-Jun, and Smads (see discussion
below). Although some have not been identiﬁed directly as GSK3
substrates, including SRF, Sox11, Id2, and KLFs (Lasorella et al.,
2006; Wickramasinghe et al., 2008; Moore et al., 2009; Jing et al.,
2011; Lin et al., 2011; Yu et al., 2011), they contain multiple and
well-conserved GSK3 sites (Taelman et al., 2010). In this section,
we summarize the functions of these proteins in regulation of axon
growth and discuss how they are regulated by the GSK3 signaling.
It should be noted that the discussion below about how GSK3 sig-
naling controls the function of these transcription factors is based
mainly on studies in non-neuronal cells and that additional studies
are required to determine if similar regulation occurs in neurons
during axon growth.
CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN
ROLE OF CREB IN AXON GROWTH AND REGENERATION
During development, several transcription factors have been
shown to control axon growth downstream of neurotrophin sig-
naling, including CREB (Lonze et al., 2002), NFATc (Graef et al.,
2003), SRF (Wickramasinghe et al., 2008), and Sox11 (Lin et al.,
2011), among which CREB and NFATc are well-established GSK3
substrates. Upon neurotrophin stimulation, CREB is activated
via Serine-133 phosphorylation downstream of the MAPK path-
way (Bonni et al., 1995; Finkbeiner et al., 1997; Arthur et al.,
2004). Inhibition of CREB activity blocks neurotrophin-mediated
sympathetic neuron survival (Riccio et al., 1999). Thus, CREB
knockout mice die shortly after birth with substantial apoptosis
of PNS neurons (Lonze et al., 2002). In vitro, CREB null sen-
sory and sympathetic neurons grew shorter axons in response to
NGF than did those of wild-type mice when cell apoptosis was
blocked by the caspase inhibitor (Lonze et al., 2002), showing that
CREB-mediated gene transcription is required for neurotrophin-
induced axon growth. However, in vivo data of CREB knockout
mice showed that axon growth was impaired at an earlier develop-
mental stage when axon growth was neurotrophin-independent.
In another study of adult mice, overexpression of an active form
of CREB in DRG neurons markedly enhanced the regeneration
of the dorsal column axons after a spinal cord injury (Gao et al.,
2004). These studies indicate thatCREB-mediated gene expression
is both necessary and sufﬁcient for supporting axon growth.
REGULATION OF CREB BY GSK3
The cAMP–PKA pathway activates CREB by phosphorylation of
its serine-133 residue, which in turn acting as a priming site for
the phosphorylation of GSK3 at serine-129. Although one study
showed that phosphorylation of CREB by GSK3 at serine-129
enhanced its transcriptional activity (Fiol et al., 1994), two later
studies showed that GSK3-mediated phosphorylation of CREB
reduced its DNA-binding activity (Bullock and Habener, 1998;
Grimes and Jope, 2001). This conclusion is consistent with the
fact the growth factor-induced CREB activation is correlated with
GSK3 inactivation. Moreover, the inhibitory effect of GSK3 on
CREB-DNA binding was reversed by treatment with multiple
GSK3 inhibitors (Grimes and Jope, 2001). Furthermore, another
study found that inhibition of GSK3 in quiescent cells alone can
directly induce the expression of multiple genes containing the
CREB binding site (Tullai et al., 2011), providing functional evi-
dence that GSK3 plays a negative role in regulation of CREB
activity.
NUCLEAR FACTOR OF ACTIVATED T-CELLS
ROLE OF NFATc IN AXON GROWTH AND REGENERATION
In addition to CREB, neurotrophins also control gene expression
via the transcription factor NFATc family proteins (NFATc1–4),
which are activated by protein phosphatase calcineurin down-
stream of calcium signaling (Hogan et al., 2003). In triple NFATc
knockout mice, sensory neurons show severe defects in axon
growth at embryonic day 10.5 (Graef et al., 2003). In vitro cul-
tured DRG explants from the mutant mice also have impaired
axon growth in response to NGF. However, these mutant neurons
extend axons normally in response to extracellular signals other
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than neurotrophins, indicating that NFATc speciﬁcally mediates
neurotrophin-induced axon growth. Interestingly, a recent study
showed that the calcium–calcineurin pathway is also required
locally at the axon to mediate neurotrophin-induced axon growth
by controlling neurotrophin receptor endocytosis independent of
transcription (Bodmer et al., 2011). This result indicates that neu-
rotrophins induce axon growth through the calcium–calcineurin
pathway by coordinating gene transcription in the neuronal soma
with local regulatory signaling in the axon.
REGULATION OF NFATc BY GSK3
Calcineurin activates NFATc via dephosphorylating multiple ser-
ine residues in their regulatory subunits, which are located on the
N-terminal to theDNA-binding domains. NFATc remains inactive
in the cytoplasm, and dephosphorylation by calcineurin exposes
a nuclear localization sequence while masking a nuclear export
sequence, thus leading to translocation of NFATc into the nucleus
and the subsequent transcriptional activation (Hogan et al., 2003).
Conversely, several kinases canphosphorylateNFATc andpromote
their export from the nucleus. GSK3 is a key export kinase that
functions to rephosphorylate NFATc and thus turns off the signal-
ing (Beals et al., 1997). In hippocampal neurons, activity-induced
NFATc translocation from cytoplasm to nucleus (and the subse-
quent gene transcription) is antagonized by the GSK3-mediated
phosphorylation of NFATc (Graef et al., 1999). One study has
shown that, in addition to negatively regulating subcellular local-
ization,GSK3-mediated phosphorylation also negatively regulates
the intrinsic DNA-binding activity of NFATc (Neal and Clipstone,
2001). Phosphorylation of NFATc by GSK3 requires prior phos-
phorylation by priming kinases, including PKA (Sheridan et al.,
2002) and DYRK1/2 (Gwack et al., 2006), providing another level
of modulation of NFATc function via GSK3.
SMADs
ROLE OF SMAD PROTEINS IN AXON GROWTH AND REGENERATION
Smad proteins are transcription factors activated downstream of
the TGFβ or the bone morphogenetic protein (BMP) signaling
pathways. Different Smad isoforms mediate gene transcription
downstream of different ligands, with Smad1, -5, and -8 acting
downstream of BMPs and Smad2 and -3 acting downstream of
the TGFβ (Schmierer and Hill, 2007). A recent study showed that
Smad1 was up-regulated and activated in DRG neurons upon
peripheral axotomy and that activation of Smad1was necessary for
the regenerative axon growth of DRG neurons in vitro (Zou et al.,
2009).A later study using neurons fromSmad1 conditional knock-
out mice showed that Smad1 was also required for axon growth
from developing DRG neurons in vitro (Parikh et al., 2011). In
addition, activation of the BMP4 signaling inDRGneurons in vivo
was sufﬁcient to promote dorsal column axon regeneration after
the spinal cord injury. Although the in vivo role of Smad1 was not
directly tested in these two studies, these results suggest that Smad1
is a key transcription factor controlling axon growth during both
development and regeneration. In contrast to Smad1, Smad2 was
shown to limit axon growth of developing cerebellar granule neu-
rons (CGNs; Stegmuller et al., 2008). Interestingly, the negative
effect of Smad2 on axon growth does not seem to depend on its
transcriptional activity. Instead, Smad2 was shown to inhibit axon
growthby facilitatingproteindegradationof another transcription
factor SnoN, which functions to promote axon growth, together
with the E3 ubiquitin ligase Cdh1–APC complex.Whether Smad2
also functions to limit axon regeneration in mature neurons is not
known. However, knocking down Smad2 overrode the inhibitory
effect of myelin on axon growth, suggesting Smad2 as a potential
therapeutic target for enhancing axon regeneration (Stegmuller
et al., 2008).
REGULATION OF SMAD PROTEINS BY GSK3
Smad1 is awell-studiedGSK3 substrate.WhenprimedwithMAPK
or CDK8/9, GSK3 can phosphorylate Smad1 at multiple sites in
its linker region (Fuentealba et al., 2007; Aragon et al., 2011).
Phosphorylation of Smad1 promotes its interaction with HECT-
domain ubiquitin ligase Smurf1 and the subsequent degradation
of Smad1 (Sapkota et al., 2007). Studies have shown that Smad2
and Smad3 can be phosphorylated by GSK3, which also leads to
their degradation via UPS (Guo et al., 2008; Aragon et al., 2011).
Unlike Smad1, degradation of Smad2/3 is mediated through a dif-
ferent E3 ligase, Nedd4L (Gao et al., 2009; Aragon et al., 2011).
Because Smad1 and Smad2/3 are negatively regulated by GSK3-
mediated protein degradation but play opposing roles in regu-
lation of axon growth, it is unclear how modulation of GSK3
signaling can control axon growth through Smad proteins. To
solve this problem, studies are needed to directly examine how
GSK3 signaling regulates Smad1 or Smad2/3 in neurons during
axon growth.
c-JUN
ROLE OF c-JUN IN AXON GROWTH AND REGENERATION
c-Jun is one of the early identiﬁed genes that are drastically up-
regulated in DRG neurons upon axotomy (Jenkins and Hunt,
1991). Importantly, substantial up-regulation of c-Jun in DRG
neurons is induced only upon peripheral axotomy, which results
in successful axon regeneration but not upon central axotomy,
which fails to produce regeneration (Broude et al., 1997). These
results suggest that c-Jun functions to regulate axon regeneration.
When c-Junwas knockedout inneural progenitors viaNestin-Cre-
mediated recombination (Raivich et al., 2004), themice developed
normally with no obvious morphological or behavioral defects in
the nervous system, indicating that c-Jun is not required for devel-
opmental axon growth. However, when axon regeneration was
assessed in these mutant mice, regeneration of facial nerve after
the injury was markedly reduced. In addition, expression of sev-
eral known axon RAGs was impaired in the mutant mice upon
the nerve injury, such as galanin and alpha7beta1 integrin. These
results support the notion that c-Jun speciﬁcally regulates axon
regeneration via controlling the expression of axon RAGs. In sup-
port, a recent study showed that knocking down c-Jun speciﬁcally
in adult DRG neurons via in vivo gene electroporation blocked
sciatic nerve axon regeneration, conﬁrming a speciﬁc role of c-Jun
in the regulation of axon regeneration (Saijilafu et al., 2011).
REGULATION OF c-JUN BY GSK3
Several early studies (Boyle et al., 1991; de Groot et al., 1993; Niko-
lakaki et al., 1993) have shown that c-Jun and two other members
of the Jun family, JunB and JunD, are all substrates of GSK3. Phos-
phorylation of c-Jun at sites near its DNA-binding domain reduces
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its DNA-binding activity and the subsequent transcription activa-
tion. Similar negative regulation of c-Jun function by GSK3 is
conserved for the drosophila GSK3 homolog shaggy (de Groot
et al., 1993). In addition to regulating the DNA-binding activity of
c-Jun,GSK3-mediated phosphorylation of c-Jun also promotes its
protein degradation through UPS (Wei et al., 2005). Lastly, there is
evidence that GSK3 also negatively regulates the activity of c-Jun
N-terminal kinase (JNK) downstream of the growth factor signal-
ing (Liu et al., 2004). Together, these studies suggest that GSK3
is a major regulator of c-Jun function by controlling its protein
stability, DNA-binding, and activation.
p53
ROLE OF p53 IN AXON GROWTH AND REGENERATION
p53 is well-known for its role as a tumor suppressor that functions
to promote apoptosis or cell cycle arrest (Levine and Oren, 2009).
In neurons, p53 has been shown to mediate cell death of sympa-
thetic neurons upon neurotrophin withdrawn (Aloyz et al., 1998).
Recent studies have revealed an important role of p53 in regulation
of axon growth (Di Giovanni et al., 2006; Qin et al., 2009; Tedeschi
et al., 2009). Overexpression of a dominant negative mutant of
p53 (p53DN) blocks axon growth from PC12 cells and primary
cultured rat cortical neurons (Di Giovanni et al., 2006). Impor-
tantly, expression of p53DN also leads to reduced expression of
two axon growth-associated genes, the actin binding protein coro-
nin1b and the GTPase Rab13, suggesting that p53 controls axon
growth by controlling the expression of axon growth-associated
genes. A later study has identiﬁed GAP43, which is one of the
best-recognized genes associated with axon growth, as a transcrip-
tional target of p53 (Tedeschi et al., 2009). The level of GAP43
mRNA is reduced by 60% in p53 knockout mice compared with
that in wild-type mice (Tedeschi et al., 2009). As a result, axon
growth of embryonic cortical neurons from the p53 null mice
in vitro is substantially impaired,providing deﬁnitive evidence that
p53 is required for axon growth in vitro. Whether p53 knockout
mice have axon growth defects in vivo during development was
not examined in that study. However, in a facial nerve axotomy
model, axon regeneration of facial motor neurons was markedly
reduced in comparison to that in wild-type mice, indicating that
p53 function is necessary for axon regeneration in vivo. In addi-
tion to regulation of axon growth as a transcription factor, p53 has
been shown to act locally at the growth cone to control growth cone
motility (Qin et al., 2009). Inhibition of p53 by inhibitors, dom-
inant negative mutants, or siRNA leads to growth cone collapse,
whereas overexpression of p53 increases the growth cone size. Such
an unexpected role of p53 in the growth cone was achieved by
antagonizing the function of Rho kinase, a well-known negative
regulator of growth cone motility. These results suggest that p53
can control axon growth via coordinating gene expression with
local regulation of growth cone motility.
REGULATION OF p53 BY GSK3
The regulation of p53 by GSK3 is mostly studied in the context of
p53-induced apoptosis and cell cycle arrest in response to stress
signals. However, the results are complex, with different studies
showing opposing effects. Several studies have shown that GSK3
negatively regulated p53 protein levels by phosphorylation of p53,
which then promoted its protein degradation via UPS (Mao et al.,
2001; Qu et al., 2004; Pluquet et al., 2005; Baltzis et al., 2007;
Boehme et al., 2008). In contrast, other studies have shown that
GSK3 could positively regulate p53 function. One study indicated
that phosphorylation of p53 by GSK3 at a different site enhanced
the transcriptional activity of p53 (Turenne and Price, 2001). Two
other studies found that GSK3 interacted with p53 and promoted
its activity independent of phosphorylation (Watcharasit et al.,
2002, 2003). Another study showed that GSK3 bound and facili-
tated p53 acetylation at lysine-373 and lysine-382 (Eom and Jope,
2009). Although acetylation of p53 at these two sites promotes
its transcriptional activity (Olsson et al., 2007), it does not play a
role in regulation of axon growth in neurons (Di Giovanni et al.,
2006). Instead, acetylation of p53 at a different site, lysine-320, is
speciﬁcally involved in controlling axon growth (DiGiovanni et al.,
2006). These studies suggest that the complex roles of GSK3 in reg-
ulation of p53 function depend on its speciﬁc post-translational
modiﬁcation of p53.
NFκB
ROLE OF NFκB IN AXON GROWTH AND REGENERATION
Nuclear factorκB is a transcription factor that usually forms a dim-
mer with two of the ﬁve subunits, including p65, c-Rel, RelB, p50,
and p52. NFκB function is negatively regulated by the inhibitor
of κB (IκB) proteins, which binds to NFκB and prevents it from
entering the nucleus (Chen and Greene, 2004). In PC12 cells, NGF
can activate NFκB through TrkA activation, and blocking such
TrkA-induced NFκB activation inhibits neurite outgrowth (Foehr
et al., 2000). In primary cultured developing nodose sensory neu-
rons, inhibition of NFκB also impairs BDNF-induced neurite
outgrowth (Gutierrez et al., 2005). Importantly, this regulatory
effect of NFκB on neurite outgrowth was observed only during a
restricted period of development, suggesting that neurons use dif-
ferent transcription factors to control neurite outgrowth during
different stages of development. Inhibition of NFκB activity also
blocks CNTF-induced neurite outgrowth from developing nodose
sensory neurons (Gallagher et al., 2007), indicating that differ-
ent signaling pathways can converge on NFκB to promote neurite
outgrowth. However, NFκB has also been shown to inhibit neurite
outgrowth fromdifferent neuronal types. For instance, in neonatal
superior cervical ganglion sympathetic neurons, enhancing NFκB
transcriptional activity by multiple approaches markedly inhibits
neurite outgrowth (Gutierrez et al., 2008). The molecular mecha-
nisms by whichNFκB plays opposing roles in regulation of neurite
outgrowth in different neurons is unclear.
REGULATION OF NFκB BY GSK3
Similar to reports of p53, studies have indicated opposing results
about how GSK3 regulates NFκB function (Bournat et al., 2000;
Hoeﬂich et al., 2000; Sanchez et al., 2003; Buss et al., 2004; Liang
and Chuang, 2006; Tullai et al., 2011). p65 Subunit of NFκB has
been shown to be a GSK3 substrate with its serine-468 phos-
phorylated by GSK3 (Buss et al., 2004). Overexpression of a
S468A mutant of p65 in p65-deﬁcient cells has been shown to
lead to higher NFκB transcriptional activity compared with wild-
type p65, indicating that GSK3-mediated phosphorylation of p65
at serine-468 negatively regulates NFκB function. Moreover, in
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primary cultured cortical astrocytes, overexpression of an active
mutant of GSK3β (S9A) induced cell apoptosis and reduced NFκB
activation (Sanchez et al., 2003), indicating that GSK3 activation
inhibits NFκB function. In another study, expression of Wnt-1 in
PC12 cells enhanced NFκB transcriptional activity and reduced
cell apoptosis induced by serumwithdrawn (Bournat et al., 2000).
Importantly, the effect of Wnt-1 expression on NFκB activation
can be mimicked by lithium or a dominant negative mutant of
GSK3β. Taken together, these studies show that GSK3 acts to
inhibit NFκB activity. In consistent with its negative role in regu-
lation of NFκB activity, inhibition of GSK3 alone in the absence
of other extracellular signals has been shown to be sufﬁcient to
activate NFκB in both neurons and non-neuronal cells (Liang and
Chuang, 2006; Tullai et al., 2011). However, when GSK3β was
knocked out, the mutant mice died prenatally primarily because
of failure of the liver function caused by reduced NFκB activ-
ity (Hoeﬂich et al., 2000). Although the molecular mechanism
remains unknown, this study suggests that GSK3β facilitates NFκB
function and it cannot be compensated by GSK3α.
In summary, most of these transcription factors are direct
GSK3 substrates. By phosphorylation of these axon growth-
associated transcription factors, GSK3 plays primarily negative
roles in the regulation of their function through controlling
their DNA-binding activities, nuclear localization, and/or protein
stability.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
It is well recognized that axon growth requires the coordinated
regulation of gene expression in the soma and axonal assembly
at the nerve growth cone. How such coordination is achieved
is one of the major unanswered questions in the axon growth
ﬁeld. GSK3 has been shown to be a key signaling molecule that
controls axonal assembly at the growth cone via regulation of mul-
tiplemicrotubule-binding proteins (Kim et al., 2011). Remarkably,
many axon growth-associated transcription factors are also regu-
lated by GSK3. Therefore, GSK3 could be a potential candidate
for the coordinated regulation of gene expression in the soma via
transcription factors and local axon assembly at the growth cone
via microtubule-binding proteins (Figure 1). Compared with the
regulation of microtubule-binding proteins by GSK3 signaling,
we know very little about how GSK3 regulates these transcrip-
tion factors in neurons. Therefore, additional studies are needed
to determine if modulation of GSK3 activity in neurons regulates
these transcription factors in a manner similar to that in non-
neuronal cells, and whether such regulation affects axon growth.
In addition to the transcription factors we have discussed, there
are many other axon growth-associated transcription factors that
are potential GSK3 substrates, including KLFs, SRF, Sox11, and
Id2, all of which contain multiple conserved GSK3 consensus sites
(Taelman et al., 2010). It will be interesting to determine if their
function canbemodulatedbyGSK3 signaling during axon growth.
GSK3 could play permissive or instructive roles in the regulation
of gene expression during axon growth. As discussed, direct inhi-
bition of GSK3 alone in the absence of extracellular signals can
activate several transcription factors in both non-neuronal cells
and neurons (Liang and Chuang, 2006; Tullai et al., 2011), sup-
porting the premise that GSK3 inactivation plays an instructive
role in directing gene expression. It will be important to investi-
gate if suchGSK3 inactivation-induced gene expression inneurons
can support axon growth.
FIGURE 1 | Glycogen synthase kinase 3 controls axon growth by
coordinating gene transcription and local microtubule dynamics in the
growth cone. GSK3 phosphorylates a number of transcription factors and
thereby controls their function and subsequent gene expression, which may
play an important part in determining the intrinsic axon growth capacity. GSK3
is also known to phosphorylate several microtubule-binding proteins, which
control distinct aspects of microtubule dynamics and assembly, and thereby
controls local axon assembly at the axonal growth cone. The ﬁnal outcome of
axon regeneration is determined by the coordination between gene
expression and local cytoskeletal assembly at the growth cone. Substrates
whose activities are inhibited by GSK3 are depicted in red, those that are
activated by GSK3 are depicted in green. Some substrates, such as p53 and
NFκB, can be either activated or inhibited upon GSK3 phosphorylation,
depending on the context. Substrates that undergo proteasomal degradation
when phosphorylated by GSK3 are depicted in purple. Putative substrates are
shown in gray.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 3 | 7
Liu et al. GSK3 signaling in axon growth
The loss of axon regeneration ability in adult CNS neu-
rons is due in part to the result of reduced intrinsic axon
growth capacity, which is regulated primarily by gene transcrip-
tion and protein translation (Liu et al., 2011). Therefore, direct
manipulation of axon growth-associated transcription factors or
their upstream regulators is emerging as an effective approach
for promoting axon regeneration. For instance, a recent study
showed that activation of the BMP–Smad1 signaling markedly
enhanced axon regeneration after the spinal cord injury (Parikh
et al., 2011). Because GSK3 signaling is involved in the regula-
tion of many transcription factors associated with axon growth,
manipulation of GSK3 signaling may be a potential approach
for promoting axon regeneration via enhancing the intrinsic
axon growth ability by activating multiple transcription factors
at the same time. Indeed, genetic deletion of Pten in adult
neurons has been shown to greatly improve axon regeneration
after an optic nerve crush or spinal cord injury (Park et al.,
2008; Liu et al., 2010). The effect of Pten deletion is partially
mediated by the mTor-mediated proteins translation. Because
Pten deletion leads to GSK3 inactivation, it is very likely that
GSK3-regulated gene transcription is also involved. In consis-
tent, systemic inhibition of GSK3 activity with pharmacological
inhibitors has been shown to promote corticospinal axon regener-
ation in vivo (Dill et al., 2008), which requires increased intrinsic
axon growth ability. It is possible that the promoting effect of
GSK3 inhibitors on axon regeneration in vivo is not neuron cell
autonomous. Therefore, future genetic studies, in which GSK3 is
speciﬁcally manipulated in neurons, are necessary to determine
if inhibition of GSK3 in vivo is able to enhance the intrinsic
axon growth ability of mature neurons and promotes CNS axon
regeneration.
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